{"id":479355,"date":"2021-04-21T07:03:55","date_gmt":"2021-04-21T11:03:55","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/athira-pharma-to-participate-in-panel-discussion-at-sachs-4th-annual-neuroscience-innovation-forum\/"},"modified":"2021-04-21T07:03:55","modified_gmt":"2021-04-21T11:03:55","slug":"athira-pharma-to-participate-in-panel-discussion-at-sachs-4th-annual-neuroscience-innovation-forum","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/athira-pharma-to-participate-in-panel-discussion-at-sachs-4th-annual-neuroscience-innovation-forum\/","title":{"rendered":"Athira Pharma to Participate in Panel Discussion at Sachs 4th\u00a0Annual Neuroscience Innovation Forum"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"left\">BOTHELL, Wash., April  21, 2021  (GLOBE NEWSWIRE) &#8212; <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=5YphrLiWYkcgaGV0jCYUo7MBRcTKEevQkbbthnvogJZ6Gs0qZDxQtD59_yaY2vPnW-RMF0RMmlMb9U9mQGU28w==\" rel=\"nofollow noopener\" target=\"_blank\">Athira Pharma, Inc.<\/a>\u00a0(NASDAQ: ATHA), a late clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal health and stop neurodegeneration,\u00a0today announced that Leen Kawas, Ph.D., President and Chief Executive Officer, will participate in a virtual panel discussion at the Sachs 4<sup>th<\/sup>\u00a0Annual Neuroscience Innovation Forum. The panel, titled \u201cProgress in Alzheimer\u2019s and Dementia,\u201d will be aired on Wednesday, April 28, 2021, at 8:30 a.m. PT \/11:30 a.m. ET.<\/p>\n<p>The panel will be moderated by Howard Fillit, M.D., Founding Executive Director at the Alzheimer\u2019s Drug Discovery Foundation, and Paul Matteis, Managing Director at Stifel, and will include a discussion with the following participants:<\/p>\n<ul type=\"disc\">\n<li>David Elmaleh, Ph.D., Chairman and Chief Scientific Officer, AZTherapies<\/li>\n<li>Todd Haim, Ph.D., Chief, Office of Small Business Research, National Institute on Aging (NIH)<\/li>\n<li>Leen Kawas, Ph.D., President and Chief Executive Officer, Athira Pharma<\/li>\n<li>Gregor Macdonald, Ph.D., Senior Director, Neuroscience Scientific Licensing, Johnson &amp; Johnson Innovation<\/li>\n<li>Deborah Rathjen, Ph.D., Executive Chair, Bioasis Technologies<\/li>\n<li>Susanne Wilke, Ph.D., President and Chief Executive Officer, Cognoptix<\/li>\n<\/ul>\n<p>To register in advance for a live webcast of the panel discussion, please click <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=qB7mkgbz8i2voRC1j8L1Dr5q8MmY6GaQgW4NKxK6QKQO1d7gZiMQnJ4xRnJPYbHlSr7hR36fK6kFKGppKp_0AGrQ8fwyFjzT1wnwf2MKAoU=\" rel=\"nofollow noopener\" target=\"_blank\">here<\/a>. For more information about the Sachs 4<sup>th<\/sup> Annual Neuroscience Innovation Forum, please refer to the <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=7RrbRSegP9RPWXgQ0reW8vJuYYZ-LZUI310Bf7289NrGd31VkNrQctmYsrLZB17_kBQNi-E2NYN5OElO_4esqvUFO5bVfvHcFwT9F9eZZDKDZgohA3PgdXDCViY7hemL\" rel=\"nofollow noopener\" target=\"_blank\">conference portal<\/a>.<\/p>\n<p>Beginning May 26, a recording of the panel will be available on the <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=mjBqV1yYK_buLaAvm-UNezAgCVQ6Qk4Js81ReKytDD_Af6a8xHT6w68a47n9pR2Pk4E-hO6Fa1ejMscEitdHqD2iRSAr6390bzFIWi_VxuCWhgc6K9BsEk1QZ1XGfaoO2v0Mz3YyoAeGG7f4Qugl2A==\" rel=\"nofollow noopener\" target=\"_blank\">Investors section<\/a> of the Athira website at\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=56AtKwVplHRIfUsk_W42czfrhudSgpkfHj0CYbf7fXks4GEqvqZaGt-EpczYQCCBlY4AWZDtgHAKgjxYiImGsTGEj7J9M8-bK6yMoN9ciVksJSAOiQIZoclBydTd0VyDO0xsY3XaM4Hc-Pja95jVFTJ6OkIaD_rQ13JYMErgL_VrFfkxquwaIJrPCNauY5QS0GeSVyfAaHTHdLeEXEMZOg==\" rel=\"nofollow noopener\" target=\"_blank\">https:\/\/investors.athira.com\/news-and-events\/events-and-presentations<\/a>. An archived replay will be available for at least 30 days.<\/p>\n<p>\n        <strong>About Athira Pharma, Inc.<\/strong><br \/>\n        <br \/>Athira, headquartered in the Seattle area, is a late clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal health and stop neurodegeneration. Athira aims to provide rapid cognitive improvement and alter the course of neurological diseases with our novel mechanism of action. Athira is currently advancing its lead therapeutic candidate, ATH-1017, a novel small molecule for Alzheimer\u2019s and Parkinson\u2019s dementia. For more information, visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=thLfSgadO9dlYlyDAOIddjulAXX6cwE92IuvscnVdMP75sV_hIvlLt7QkuNu7-q5DT554pjbgmy6-XNMycVv_g==\" rel=\"nofollow noopener\" target=\"_blank\">www.athira.com<\/a>. You can also follow Athira on <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=VYRzRTPLEIknJu9amvcs838JQNC8tDnDQ4KX3ooUlccgXY5HaHWgHvLUjbgXotk363GGtiOSuTn5Htnq4LgVF-mzvqGXIaSPuZmhNfxSqKk=\" rel=\"nofollow noopener\" target=\"_blank\">Facebook<\/a>, <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=sldYgvSbKbiqCWNjnvnoWzQ_b5IQsjLzqrM05BK2cOiAvcLTV43ry7Jtn359smNbzx76ZiaeAWh6MP290Nb3l6b3D9hGflQ_Ilu9tD6aeag=\" rel=\"nofollow noopener\" target=\"_blank\">LinkedIn<\/a>\u00a0and\u00a0@athirapharma on <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=dRYxCFlKE8woYwHE3n2OavogdOb6JZL2b7IaJ2iIi3ViuLAsDumGhR-1y9qaRKuFYGUlq30275QTfL92grgdktRv82echPZFsoe9ehXg3-o=\" rel=\"nofollow noopener\" target=\"_blank\">Twitter<\/a> and <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=s8Z9472wp87yJV-tit0e6suvbVnr2GTp-XLN19FGuqQQUciYjI1i1GrQstbPKCMhPhQ03HfN5yLPmg7AEbxoZ2wCqpdRIgExktL2K9nDUQ4=\" rel=\"nofollow noopener\" target=\"_blank\">Instagram<\/a>.<\/p>\n<p>\n        <strong>Investor &amp; Media Contact<\/strong>:<br \/>Julie Rathbun<br \/>Athira Pharma<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=8TI57BFxbmtx92XNybu3rtlKFQ3WVVCWRegrYD85VyKI9QSYy3_GQNpQgE8Le9ARZ_0waXO9Rkus-b2A2Gk14Ymr3XD-tTk5SL_UGs_H7N8=\" rel=\"nofollow noopener\" target=\"_blank\">Julie.rathbun@athira.com<\/a><br \/>206-769-9219<\/p>\n<\/p>\n<p>      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIyMDY2NiM0MTMxMTQ2IzIyMDE4OTE=\" width=\"1\" height=\"1\" \/><br \/>\n      <br \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/ml.globenewswire.com\/release\/track\/602175b0-e860-46ab-8eee-5b6a8419d76e\" width=\"1\" height=\"1\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>BOTHELL, Wash., April 21, 2021 (GLOBE NEWSWIRE) &#8212; Athira Pharma, Inc.\u00a0(NASDAQ: ATHA), a late clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal health and stop neurodegeneration,\u00a0today announced that Leen Kawas, Ph.D., President and Chief Executive Officer, will participate in a virtual panel discussion at the Sachs 4th\u00a0Annual Neuroscience Innovation Forum. The panel, titled \u201cProgress in Alzheimer\u2019s and Dementia,\u201d will be aired on Wednesday, April 28, 2021, at 8:30 a.m. PT \/11:30 a.m. ET. The panel will be moderated by Howard Fillit, M.D., Founding Executive Director at the Alzheimer\u2019s Drug Discovery Foundation, and Paul Matteis, Managing Director at Stifel, and will include a discussion with the following participants: David Elmaleh, Ph.D., Chairman and Chief Scientific Officer, AZTherapies Todd &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/athira-pharma-to-participate-in-panel-discussion-at-sachs-4th-annual-neuroscience-innovation-forum\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Athira Pharma to Participate in Panel Discussion at Sachs 4th\u00a0Annual Neuroscience Innovation Forum&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-479355","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Athira Pharma to Participate in Panel Discussion at Sachs 4th\u00a0Annual Neuroscience Innovation Forum - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/athira-pharma-to-participate-in-panel-discussion-at-sachs-4th-annual-neuroscience-innovation-forum\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Athira Pharma to Participate in Panel Discussion at Sachs 4th\u00a0Annual Neuroscience Innovation Forum - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"BOTHELL, Wash., April 21, 2021 (GLOBE NEWSWIRE) &#8212; Athira Pharma, Inc.\u00a0(NASDAQ: ATHA), a late clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal health and stop neurodegeneration,\u00a0today announced that Leen Kawas, Ph.D., President and Chief Executive Officer, will participate in a virtual panel discussion at the Sachs 4th\u00a0Annual Neuroscience Innovation Forum. The panel, titled \u201cProgress in Alzheimer\u2019s and Dementia,\u201d will be aired on Wednesday, April 28, 2021, at 8:30 a.m. PT \/11:30 a.m. ET. The panel will be moderated by Howard Fillit, M.D., Founding Executive Director at the Alzheimer\u2019s Drug Discovery Foundation, and Paul Matteis, Managing Director at Stifel, and will include a discussion with the following participants: David Elmaleh, Ph.D., Chairman and Chief Scientific Officer, AZTherapies Todd &hellip; Continue reading &quot;Athira Pharma to Participate in Panel Discussion at Sachs 4th\u00a0Annual Neuroscience Innovation Forum&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/athira-pharma-to-participate-in-panel-discussion-at-sachs-4th-annual-neuroscience-innovation-forum\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-04-21T11:03:55+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIyMDY2NiM0MTMxMTQ2IzIyMDE4OTE=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/athira-pharma-to-participate-in-panel-discussion-at-sachs-4th-annual-neuroscience-innovation-forum\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/athira-pharma-to-participate-in-panel-discussion-at-sachs-4th-annual-neuroscience-innovation-forum\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Athira Pharma to Participate in Panel Discussion at Sachs 4th\u00a0Annual Neuroscience Innovation Forum\",\"datePublished\":\"2021-04-21T11:03:55+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/athira-pharma-to-participate-in-panel-discussion-at-sachs-4th-annual-neuroscience-innovation-forum\\\/\"},\"wordCount\":363,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/athira-pharma-to-participate-in-panel-discussion-at-sachs-4th-annual-neuroscience-innovation-forum\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODIyMDY2NiM0MTMxMTQ2IzIyMDE4OTE=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/athira-pharma-to-participate-in-panel-discussion-at-sachs-4th-annual-neuroscience-innovation-forum\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/athira-pharma-to-participate-in-panel-discussion-at-sachs-4th-annual-neuroscience-innovation-forum\\\/\",\"name\":\"Athira Pharma to Participate in Panel Discussion at Sachs 4th\u00a0Annual Neuroscience Innovation Forum - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/athira-pharma-to-participate-in-panel-discussion-at-sachs-4th-annual-neuroscience-innovation-forum\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/athira-pharma-to-participate-in-panel-discussion-at-sachs-4th-annual-neuroscience-innovation-forum\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODIyMDY2NiM0MTMxMTQ2IzIyMDE4OTE=\",\"datePublished\":\"2021-04-21T11:03:55+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/athira-pharma-to-participate-in-panel-discussion-at-sachs-4th-annual-neuroscience-innovation-forum\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/athira-pharma-to-participate-in-panel-discussion-at-sachs-4th-annual-neuroscience-innovation-forum\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/athira-pharma-to-participate-in-panel-discussion-at-sachs-4th-annual-neuroscience-innovation-forum\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODIyMDY2NiM0MTMxMTQ2IzIyMDE4OTE=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODIyMDY2NiM0MTMxMTQ2IzIyMDE4OTE=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/athira-pharma-to-participate-in-panel-discussion-at-sachs-4th-annual-neuroscience-innovation-forum\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Athira Pharma to Participate in Panel Discussion at Sachs 4th\u00a0Annual Neuroscience Innovation Forum\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Athira Pharma to Participate in Panel Discussion at Sachs 4th\u00a0Annual Neuroscience Innovation Forum - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/athira-pharma-to-participate-in-panel-discussion-at-sachs-4th-annual-neuroscience-innovation-forum\/","og_locale":"en_US","og_type":"article","og_title":"Athira Pharma to Participate in Panel Discussion at Sachs 4th\u00a0Annual Neuroscience Innovation Forum - Market Newsdesk","og_description":"BOTHELL, Wash., April 21, 2021 (GLOBE NEWSWIRE) &#8212; Athira Pharma, Inc.\u00a0(NASDAQ: ATHA), a late clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal health and stop neurodegeneration,\u00a0today announced that Leen Kawas, Ph.D., President and Chief Executive Officer, will participate in a virtual panel discussion at the Sachs 4th\u00a0Annual Neuroscience Innovation Forum. The panel, titled \u201cProgress in Alzheimer\u2019s and Dementia,\u201d will be aired on Wednesday, April 28, 2021, at 8:30 a.m. PT \/11:30 a.m. ET. The panel will be moderated by Howard Fillit, M.D., Founding Executive Director at the Alzheimer\u2019s Drug Discovery Foundation, and Paul Matteis, Managing Director at Stifel, and will include a discussion with the following participants: David Elmaleh, Ph.D., Chairman and Chief Scientific Officer, AZTherapies Todd &hellip; Continue reading \"Athira Pharma to Participate in Panel Discussion at Sachs 4th\u00a0Annual Neuroscience Innovation Forum\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/athira-pharma-to-participate-in-panel-discussion-at-sachs-4th-annual-neuroscience-innovation-forum\/","og_site_name":"Market Newsdesk","article_published_time":"2021-04-21T11:03:55+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIyMDY2NiM0MTMxMTQ2IzIyMDE4OTE=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/athira-pharma-to-participate-in-panel-discussion-at-sachs-4th-annual-neuroscience-innovation-forum\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/athira-pharma-to-participate-in-panel-discussion-at-sachs-4th-annual-neuroscience-innovation-forum\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Athira Pharma to Participate in Panel Discussion at Sachs 4th\u00a0Annual Neuroscience Innovation Forum","datePublished":"2021-04-21T11:03:55+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/athira-pharma-to-participate-in-panel-discussion-at-sachs-4th-annual-neuroscience-innovation-forum\/"},"wordCount":363,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/athira-pharma-to-participate-in-panel-discussion-at-sachs-4th-annual-neuroscience-innovation-forum\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIyMDY2NiM0MTMxMTQ2IzIyMDE4OTE=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/athira-pharma-to-participate-in-panel-discussion-at-sachs-4th-annual-neuroscience-innovation-forum\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/athira-pharma-to-participate-in-panel-discussion-at-sachs-4th-annual-neuroscience-innovation-forum\/","name":"Athira Pharma to Participate in Panel Discussion at Sachs 4th\u00a0Annual Neuroscience Innovation Forum - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/athira-pharma-to-participate-in-panel-discussion-at-sachs-4th-annual-neuroscience-innovation-forum\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/athira-pharma-to-participate-in-panel-discussion-at-sachs-4th-annual-neuroscience-innovation-forum\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIyMDY2NiM0MTMxMTQ2IzIyMDE4OTE=","datePublished":"2021-04-21T11:03:55+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/athira-pharma-to-participate-in-panel-discussion-at-sachs-4th-annual-neuroscience-innovation-forum\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/athira-pharma-to-participate-in-panel-discussion-at-sachs-4th-annual-neuroscience-innovation-forum\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/athira-pharma-to-participate-in-panel-discussion-at-sachs-4th-annual-neuroscience-innovation-forum\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIyMDY2NiM0MTMxMTQ2IzIyMDE4OTE=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIyMDY2NiM0MTMxMTQ2IzIyMDE4OTE="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/athira-pharma-to-participate-in-panel-discussion-at-sachs-4th-annual-neuroscience-innovation-forum\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Athira Pharma to Participate in Panel Discussion at Sachs 4th\u00a0Annual Neuroscience Innovation Forum"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/479355","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=479355"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/479355\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=479355"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=479355"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=479355"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}